A Study of E7080 in Subjects With Solid Tumor

Summary

The purpose of this study is to investigate the tolerability and safety of E7080 up to 24 mg when administered orally on a once daily continuous dose schedule in cycles (4 weeks as 1 cycle) in subjects with solid tumors

Timeline

Start

2011-02

Primary completion

2011-12

Completion

2013-04

Drugs

Indications